Overview

• Founded in 1989, Curran Partners, Inc. operates as a U.S.-based member of the ECI Group since 2003, leveraging a global network of executive search firms with offices in major cities worldwide.
• Specializes in recruiting executives for life sciences and biotechnology companies preparing for drug development, regulatory approval, and market entry, with a focus on high-stakes, regulated environments.
• Generates annual revenue of $6,281,000 with a lean team of 6 employees headquartered at 6 Landmark Sq, Stamford, Connecticut, 06901.
• Member of the Association of Executive Search Consultants (AESC) since 1998, emphasizing adherence to professional standards in executive search.
• Serves clients in biotechnology, life sciences, consumer products, industrial products, and business services, with a strategic emphasis on human capital as a competitive differentiator.

Specializations

• Biotechnology and life sciences sector recruitment, particularly for companies in late-stage drug development and regulatory approval phases.
• Executive search for roles in clinical development, regulatory affairs (healthcare), and commercial functions within highly regulated industries.
• Recruitment of C-suite and senior leaders in general management, research, finance, and business development for high-growth life sciences organizations.
• Talent acquisition for organizations requiring expertise in navigating FDA or international regulatory pathways for new therapies.

Services & Approach

• Executive search services for biotechnology and life sciences companies preparing for clinical trials or product commercialization.
• Global talent acquisition through the ECI Group network, enabling cross-border recruitment in major international markets.
• Leadership recruitment for specialized roles including clinical development directors, regulatory affairs executives, and commercial operations heads.
• Strategic staffing solutions for consumer products, industrial sectors, and business services firms alongside core life sciences focus.